Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
Stock Information for Citius Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.